npj Precision Oncology : Impact Factor & More
eISSN: 2397-768XpISSN: 2397-768X
Open AccessShare this on:
Key Metrics
CiteScore 
9.1
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SNIP
2.14
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on npj Precision Oncology
npj Precision Oncology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | NATURE PORTFOLIO |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 2990 | USD 3490 | GBP 2690 |
| Publication Time | 18 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | The Hormel Institute, University of Minnesota |
| Frequency | Continuous publication |
| Publication Start Year | 2017 |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in npj Precision Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in npj Precision Oncology
GLP-1 receptor agonist targets an AMPKα1-HIF1α-PFKFB3 metabolic vulnerability and enhances Lenvatinib response in hepatocellular carcinoma.
- 29 Jun 2026
- NPJ precision oncology
Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis.
- 29 Jun 2026
- NPJ precision oncology
Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks.
- 24 Jun 2026
- NPJ precision oncology
ImmuGT-ConRes: a consistency learning residual network for predicting pan-cancer immunotherapy response from gene expression data.
- 23 Jun 2026
- NPJ precision oncology
Nucleic sexual hormone receptor signaling pathways in breast cancer: function regulation, crosstalk, and therapeutic implications.
- 22 Jun 2026
- NPJ precision oncology
Deep learning-enabled single-cell morpholomic atlas of nasal swabs distinguishes chronic inflammation from sinonasal malignancy.
- 22 Jun 2026
- NPJ precision oncology
GLP-1 receptor agonist targets an AMPKα1-HIF1α-PFKFB3 metabolic vulnerability and enhances Lenvatinib response in hepatocellular carcinoma.
- 29 Jun 2026
- NPJ precision oncology
Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis.
- 29 Jun 2026
- NPJ precision oncology
Evaluating neoantigen-vaccine responses through mechanistic and model-based frameworks.
- 24 Jun 2026
- NPJ precision oncology
ImmuGT-ConRes: a consistency learning residual network for predicting pan-cancer immunotherapy response from gene expression data.
- 23 Jun 2026
- NPJ precision oncology
Nucleic sexual hormone receptor signaling pathways in breast cancer: function regulation, crosstalk, and therapeutic implications.
- 22 Jun 2026
- NPJ precision oncology
Deep learning-enabled single-cell morpholomic atlas of nasal swabs distinguishes chronic inflammation from sinonasal malignancy.
- 22 Jun 2026
- NPJ precision oncology
FAQs on npj Precision Oncology
How long has npj Precision Oncology been actively publishing? 
What is the publishing frequency of npj Precision Oncology?
How many articles did npj Precision Oncology publish last year?
What is the eISSN & pISSN for npj Precision Oncology?
What is Citescore for npj Precision Oncology?
What is SNIP score for npj Precision Oncology?
Who is the publisher of npj Precision Oncology?
